Wolverine – BPC-157 10mg, TB-500 (TB4) 10mg (20mg Blend)
$109.99
- BPC-157: 10mg
- TB-500 (TB4): 10mg
- Total Material: 20mg
- Vial Size: 3mL
- BPC-157 Molecular Formula: C62H98N16O22
- BPC-157 Molecular Weight: 1419.556 g/mol
- BPC-157 PubChem CID: 9941957
- TB-500 Molecular Formula: C212H350N56O78S
- TB-500 Molecular Weight: 4963 g/mol
- TB-500 PubChem CID: 16132341
- Intended Use: Controlled laboratory research only
50 in stock
Wolverine BPC 157 10mg / TB-500 10mg – Advanced 20mg Research Blend
Wolverine BPC 157 10mg / TB-500 10mg is a two-component peptide research blend containing 20mg total specified material in a 3mL vial. The formulation combines equal listed quantities of BPC-157 and TB-500 (TB4), with separate molecular specifications supplied for each component.
The combination format allows researchers to document both materials within a single clearly specified laboratory product.
Wolverine BPC 157 Research Blend Overview
The supplied formulation contains:
| Specification | BPC-157 | TB-500 (TB4) |
|---|---|---|
| Quantity | 10mg | 10mg |
| Molecular Formula | C62H98N16O22 | C212H350N56O78S |
| Molecular Weight | 1419.556 g/mol | 4963 g/mol |
| PubChem CID | 9941957 | 16132341 |
| CAS Number | 137525-51-0 | 77591-33-4 |
Total Material: 20mg
Vial Size: 3mL
These quantities describe the supplied research material and do not establish a human dose, administration schedule, or universal experimental concentration.
BPC-157 10mg Molecular Specifications
The first component of the Wolverine BPC 157 blend contains 10mg of BPC-157.
Its supplied sequence is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
The molecular formula is:
C62H98N16O22
The supplied molecular weight is 1419.556 g/mol, PubChem CID is 9941957, and CAS number is 137525-51-0.
Researchers can examine records associated with the supplied formula through the PubChem molecular formula search for C62H98N16O22.
These specifications provide multiple reference points for laboratory identification.
TB-500 10mg Molecular Specifications
The second component contains 10mg of TB-500 (TB4).
Its supplied sequence is:
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH
The supplied molecular formula is:
C212H350N56O78S
Its molecular weight is 4963 g/mol, PubChem CID is 16132341, and CAS number is 77591-33-4.
Researchers can examine records associated with this formula through the PubChem molecular formula search for C212H350N56O78S.
20mg Two-Component Research Formulation
This Wolverine formulation contains equal listed quantities of the two research materials:
BPC-157: 10mg
TB-500 (TB4): 10mg
Together, the two components provide 20mg total specified material.
Research involving the complete blend should be distinguished from studies examining either component independently. Findings associated with an isolated peptide should not automatically be generalized to the combined formulation.
BPC Wolverine Search Terminology
Researchers and search users may encounter alternative terminology such as bpc wolverine, wolverine bpc, and other variations when looking for this product.
The supplied product itself contains two separately identified materials.
For laboratory documentation, molecular characteristics are more precise than keyword formatting. Researchers can therefore reference the sequences, molecular formulas, molecular weights, PubChem identifiers, and CAS numbers supplied for both components.
Wolverine BPC 157 Molecular Identification
Accurate identification of the Wolverine BPC 157 formulation should account for both components rather than relying only on the Wolverine product name.
The BPC component is identified through its supplied sequence, C62H98N16O22 formula, 1419.556 g/mol molecular weight, PubChem CID 9941957, and CAS 137525-51-0.
The TB4 component is independently identified by its supplied sequence, C212H350N56O78S formula, 4963 g/mol molecular weight, PubChem CID 16132341, and CAS 77591-33-4.
These specifications can be incorporated into research records when comparing materials or experimental findings.
Peptides Wolverine Research Context
The search phrase peptides wolverine reflects broader interest in the combination product.
For controlled research, however, the commercial formulation name should be considered alongside the exact identity of its individual components.
Relevant experimental considerations may include:
- Identity of both materials
- Individual material quantities
- Molecular characteristics
- Experimental concentration
- Research model
- Appropriate controls
- Exposure conditions
- Analytical methodology
- Experimental endpoints
- Reproducibility
The complete formulation should be evaluated according to the conditions under which it is actually investigated.
3mL Research Vial
The complete 20mg blend is supplied in a 3mL vial.
The vial capacity is a physical product specification and does not establish final preparation volume, experimental concentration, or administration amount.
No solvent, reconstitution procedure, storage condition, or experimental concentration was supplied in the provided specifications.
Those details are therefore not being inferred or invented.
Laboratory Documentation
Research records for the Wolverine BPC 157 formulation can include both product-level and component-level information.
Product-level records may include:
BPC-157: 10mg
TB-500 (TB4): 10mg
Total Material: 20mg
Vial Capacity: 3mL
Component-level records can additionally include the sequences, molecular formulas, molecular weights, PubChem identifiers, and CAS numbers.
Researchers may also document experiment-specific variables such as concentration, controls, research model, methodology, observation conditions, and measured endpoints.
Evaluating Scientific Literature
When evaluating scientific publications, researchers should distinguish between research involving an individual component and research involving a combination.
Important comparison factors include:
- Exact molecular identity
- Individual components
- Experimental concentration
- Research model
- Study design
- Appropriate controls
- Exposure conditions
- Analytical methodology
- Measured endpoints
Evidence involving BPC-157 independently should not automatically be interpreted as evidence concerning the complete blend.
The same distinction applies to studies involving TB-500 or TB4 independently.
Related OROS Research Materials
Researchers can review Cartalax 20mg as a separately specified peptide research material.
Another catalog option is CJC-1295 No DAC 5mg.
Researchers can also explore CJC-1295 DAC 5mg and the CJC-1295 5mg / Ipamorelin 5mg blend.
Each product has separate molecular specifications and should be evaluated independently.
Scientific Research Resources
Researchers can use PubChem to investigate available molecular records and chemical identifiers.
Peer-reviewed biomedical and experimental literature can be searched through PubMed.
The exact material, molecular identity, research model, experimental conditions, controls, methodology, and endpoints should be verified before comparing findings across different studies.
Research FAQ
What is Wolverine BPC 157?
Wolverine BPC 157 is the product designation used here for a research blend containing 10mg BPC-157 and 10mg TB-500 (TB4).
How much total material does the blend contain?
The two listed components provide 20mg total specified research material.
What is the BPC-157 sequence?
The supplied sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
What is the BPC-157 PubChem CID?
The supplied PubChem CID is 9941957.
What is the TB-500 PubChem CID?
The supplied identifier is 16132341.
What are the CAS numbers?
The supplied CAS number for BPC-157 is 137525-51-0, while the supplied CAS number for TB-500 (TB4) is 77591-33-4.
What size vial is supplied?
The formulation is supplied in a 3mL vial.
Does the vial size establish experimental concentration?
No. The vial capacity does not independently establish a preparation volume or experimental concentration.
Research Use Disclaimer
This Wolverine BPC 157 / TB-500 blend is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Material quantities and vial capacity are research specifications and do not constitute human dosing or administration guidance. This information does not provide instructions for injection, self-administration, therapeutic use, diagnosis, treatment, athletic performance enhancement, bodybuilding, or veterinary application.
| Net Weight |
20mg |
|---|---|
| Brand |
OROS Research |
| Format |
Lyophilized Vial |

Reviews
There are no reviews yet.